DeutschNewstral
Article
businessdayonline.com on 2018-06-29 14:38
Novartis slims down with $25bn spin-off of Alcon eyecare business
Related news
- FNovartis to spin off $25bn Alcon eyecare businessft.com
Novartis Considers Alcon Spin-OffForbes
Novartis launches $5 billion share buyback, mulls Alcon spin-offReuters
Struggling Alcon shows some progress as Novartis weighs spinoffStar Telegram- Novartis says 'never say never' to Alcon disposalReuters
- Pharmakonzern Novartis treibt Alcon-Börsengang voranReuters
- Novartis open global data center at Alcon in Fort WorthStar Telegram
- Trennung von Novartis kommt Augenheilkonzern Alcon teuer zu stehenReuters
Novartis replaces Alcon CEO, restructures its businessbizjournals.com
Novartis Posts Sales Growth as It Slims Downwsj.com- Fort Worth’s Alcon spun off Novartis, now trading on NYSEStar Telegram
- Novartis Weighs Spinning Off Alcon Eye-Care Unitwsj.com
- LGlobal Artificial Tear Liquid Market 2021: SWOT Analysis of Key Driving Factors for Growing CAGR Value | Top Brands: Allergan, Similasan Corporation, Abbott, Alcon (Novartis), Rohto, Bausch & Lomb,…liverpoolstudentmedia.com
- LNaphazoline Hydrochloride Market 2021-2026 Size and Share, Recent Enhancements and Regional Analysis | Key Companies: Novartis AG, Alcon, Bausch & Lomb Inc, Allergan, Inc., Visine, Meda Pharmaceuti…liverpoolstudentmedia.com
Novartis AG: Novartis plans to spin off Sandoz in OctoberFinancial Times
Novartis calls $US1.2M deal with Trump lawyer's firm a 'mistake'Sydney Morning Herald
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Actionjdsupra.com- Novartis AG To Spin-Off Sandoz Business In 4Q23Forbes
- A Year In, Novartis’ Boss Faces The WorldForbes
- Schweizer Augenheilkonzern Alcon verfehlt RenditezielReuters